Regulatory efficacy of spirulina platensis protease hydrolyzate on lipid metabolism and gut microbiota in high-fat diet-fed rats

International Journal of Molecular Sciences

Volumn 19, Issue 12, 2018, Pages

  Hua, Pengpeng ^a   Yu, Zhiying ^a   Xiong, Yu ^a   Liu, Bin ^a   Zhao, Lina ^a  

^a FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

Author keywords

Gene expression; Gut microbiota; Lipid metabolism disorder; Peptides; Spirulina platensis protease hydrolyzate

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; AGENTS AFFECTING LIPID METABOLISM; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SPIRULINA EXTRACT; SPIRULINA PLATENSIS PROTEASE HYDROLYZATE EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PEPTIDE HYDROLASE; PROTEIN HYDROLYSATE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHROSPIRA PLATENSIS; ARTICLE; BIOCHEMISTRY; BIOINFORMATICS; BODY WEIGHT GAIN; CHOLESTEROL BLOOD LEVEL; DOWN REGULATION; DRUG EFFICACY; FATTY LIVER; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INTESTINE FLORA; LIPID DIET; LIPID METABOLISM; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LIVER FUNCTION; LIVER HOMOGENATE; LIVER TISSUE; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; LIVER; MALE; METABOLISM; OBESITY; SERUM; SPIRULINA;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; LIPID METABOLISM; LIPOPROTEINS, HDL; LIVER; MALE; OBESITY; PEPTIDE HYDROLASES; PROTEIN HYDROLYSATES; RATS; SERUM; SPIRULINA; TRIGLYCERIDES;

EID: 85058880188     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19124023     Document Type: Article

References (81)

1. Abliz, A.; Aji, Q.; Abdusalam, E.; Sun, X.; Abdurahman, A.; Zhou, W.; Moore, N.; Umar, A. Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia. J. Ethnopharmacol. 2014, 151, 970–974. [CrossRef] [PubMed]
2. Fidèle, N.; Joseph, B.; Emmanuel, T.; Théophile, D. Hypolipidemic, antioxidant and anti-atherosclerogenic effect of aqueous extract leaves of Cassia. occidentalisLinn (Caesalpiniaceae) in diet-induced hypercholesterolemic rats. BMC Complement. Altern. Med. 2017, 17, 76–86. [CrossRef] [PubMed]
3. Yuan, F.; Dong, H.; Fang, K.; Gong, J.; Lu, F. Effects of green tea on lipid metabolism in overweight or obese people: A meta-analysis of randomized controlled trials. Mol. Nutr. Food Res. 2017, 62, 1601122–1601134. [CrossRef] [PubMed]
4. Kwon, E.Y.; Jung, U.J.; Park, T.; Yun, J.W.; Choi, M.S. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes 2015, 64, 1658–1669. [CrossRef] [PubMed]
5. Hurt, R.T.; Edakkanambeth, V.J.; Ebbert, J.O. New pharmacological treatments for the management of obesity. Curr. Gastroenterol. Rep. 2014, 16, 394. [CrossRef] [PubMed]
6. Rodgers, R.J.; Tschöp, M.H.; Wilding, J.H. Anti-obesity drugs: Past, present and future. Dis. Model. Mech. 2012, 5, 621–626. [CrossRef] [PubMed]
7. Tung, Y.T.; Chen, H.L.; Wu, H.S.; Ho, M.H.; Chong, K.Y.; Chen, C.M. Kefir Peptides Prevent Hyperlipidemia and Obesity in High Fat Diet-Induced Obese Rats via Lipid Metabolism Modulation. Mol. Nutr. Food Res. 2017, 62. [CrossRef]
8. Baldassano, S.; Amato, A.; Caldara, G.F.; Mulè, F. Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet. Endocrine 2016, 54, 1–9. [CrossRef]
9. Kusumoto, Y.; Irie, J.; Iwabu, K.; Tagawa, H.; Itoh, A.; Kato, M.; Kobayashi, N.; Tanaka, K.; Kikuchi, R.; Fujita, M.; et al. Bile acid binding resin prevents fat accumulation through intestinal microbiota in high-fat diet-induced obesity in mice. Metab. Clin. Exp. 2017, 71, 1–6. [CrossRef]
10. Zhang, W.L.; Zhu, L.; Jiang, J.G. Active ingredients from natural botanicals in the treatment of obesity. Obes. Rev. 2015, 15, 957–967. [CrossRef]
11. Le, T.M.; Knulst, A.C.; Röckmann, H. Anaphylaxis to Spirulina confirmed by skin prick test with ingredients of Spirulina tablets. Food Chem. Toxicol. 2014, 74, 309–310. [CrossRef] [PubMed]
12. Piñero Estrada, J.E.; Bermejo, B.P.; Am, V.D.F. Antioxidant activity of different fractions of Spirulina platensis protean extract. Farmaco 2001, 56, 497–500. [CrossRef]
13. Abdelkhalek, N.K.; Ghazy, E.W.; Abdel-Daim, M.M. Pharmacodynamic interaction of Spirulina platensis and deltamethrin in freshwater fish Nile tilapia, Oreochromis niloticus: Impact on lipid peroxidation and oxidative stress. Environ. Sci. Pollut. Res. 2015, 22, 3023–3031. [CrossRef] [PubMed]
14. Mao, T.K.; Van, D.W.J.; Med, M.E.J. Effect of spirulina on the secretion of cytokines from peripheral blood mononuclear cells. Food 2000, 3, 135–175. [CrossRef] [PubMed]
15. Khan, Z.; Bhadouria, P.; Bisen, P.S. Nutritional and therapeutic potential of Spirulina. Curr. Pharm. Biotechnol. 2005, 6, 373–379. [CrossRef] [PubMed]
16. Abdeldaim, M.M.; Farouk, S.M.; Madkour, F.F.; Azab, S.S. Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic acid-induced rat experimental colitis. Immunopharmacol. Immunotoxicol. 2015, 37, 126–139. [CrossRef]
17. Upasan, C.D.; Balaraman, R. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous antioxidants in rats. Phytother. Res. 2010, 17, 330–334. [CrossRef]
18. Upasani, C.D.; Khera, A.; Balarama, R. Effect of lead with vitamin E, C, or Spirulina on malondialdehyde, conjugated dienes and hydroperoxides in rats. Indian J. Exp. Biol. 2001, 39, 70–74.
19. Zhang, H.Q.; Lin, A.P.; Sun, Y.; Deng, Y.M. Chemo-and radio-protective effects of polysaccharide of Spirulina platensis on hemopoietic system of mice and dogs. Acta Pharmacol. Sin. 2001, 22, 1121–1124.
20. Iwata, K.; Inayama, T.; Kato, T. Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol. 1990, 36, 165. [CrossRef]
21. Pérez-Vega, J.; Olivera-Castillo, A.L.; Gómez-Rui, J.Á.; Hernández-Ledesma, B. Release of multifunctional peptides by gastrointestinal digestion of sea cucumber (Isostichopus badionotus). J. Funct. Foods 2013, 5, 869–877. [CrossRef]
22. Balakumar, P.; Balakumar, M.; Arora, K.; Singh, M. Emerging role of PPAR ligands in the management of diabetic nephropathy. Pharmacol. Res. 2009, 60, 170–173. [CrossRef] [PubMed]
23. Balakumar, P.; Rose, M.; Singh, M. PPAR ligands: Are they potential agents for cardiovascular disorders? Pharmacology 2007, 80, 1–10. [CrossRef] [PubMed]
24. Contreras, A.V.; Torres, N.; Tovar, A.R. SPAR-α as a key nutritional and environmental sensor for metabolic adaptation. Advances in Nutrition: An International. Rev. J. 2013, 4, 439–452. [CrossRef]
25. Yuan, H.D.; Kim, S.J.; Quan, H.Y.; Im, B.O.; Chung, S.H.; Lee, K.H.; Cho, D.H.; Cho, J.Y. Ginseng Leaf Extract Prevents High Fat Diet-Induced Hyperglycemia and Hyperlipidemia through AMPK Activation. J. Ginseng. Res. 2010, 34, 369–375. [CrossRef]
26. Velagapudi, V.R.; Hezaveh, R.; Reigstad, C.S.; Gopalacharyulu, P.; Yetukuri, L.; Islam, S.; Felin, J.; Perkins, R.; Borén, J.; Oresic, M.; et al. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 2010, 51, 1101–1112. [CrossRef] [PubMed]
27. Lakhan, S.E.; Kirchgessner, A. Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J. Transl. Med. 2011, 9, 202–208. [CrossRef] [PubMed]
28. Saad, M.J.; Santos, A.; Prada, P.O. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology 2016, 31, 283–293. [CrossRef] [PubMed]
29. Turnbaugh, P.J.; Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Knight, R.; Gordon, J.I. The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice. Sci. Transl. Med. 2009, 1, 6. [CrossRef] [PubMed]
30. Gu, Y.; Wu, J. LC-MS/MS coupled with QSAR modeling in characterising of angiotensin I-converting enzyme inhibitory peptides from soybean proteins. Food Chem. 2013, 141, 2682–2690. [CrossRef] [PubMed]
31. Qi, S.Z.; Li, N.; Tuo, Z.D.; Li, J.L.; Xing, S.S.; Li, B.B.; Zhang, L.; Lee, H.S.; Chen, J.G.; Cui, L. Effects of Morus root bark extract and active constituents on blood lipids in hyperlipidemia rats. J. Ethnopharmacol. 2016, 180, 54–59. [CrossRef]
32. Song, Y.; Lee, S.J.; Jang, S.H.; Ji, H.H.; Song, Y.M.; Ko, Y.G.; Kim, H.D.; Min, W.; Kang, S.N.; Cho, J.H. Sasa borealis stem extract attenuates hepatic steatosis in high-fat diet-induced obese rats. Nutrients 2014, 6, 2179–2195. [CrossRef] [PubMed]
33. Lópezmartí, J.; Díazsilva, M.; Salas, A.; Del, M.G.M.; Fernández-López, J.; Remesar, X.; Alemany, M.; Fernándezlópez, J. Oleoyl-estrone induces the massive loss of body weight in Zucker fa/fa rats fed a high-energy hyperlipidic diet. J. Nutr. Biochem. 2000, 11, 530–535. [CrossRef]
34. Kusunoki, M.; Hara, T.; Tsutsumi, K.; Nakamura, T.; Miyata, T.; Sakakibara, F.; Sakamoto, S.; Ogawa, H.; Nakaya, Y.; Storlien, L.H. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia 2000, 43, 875–880. [CrossRef] [PubMed]
35. Woo, M.N.; Bok, S.H.; Lee, M.K.; Kim, H.J.; Jeon, S.M.; Do, J.M.; Shin, S.K.; Ha, T.Y.; Choi, M.S. Anti-obesity and hypolipidemic effects of a proprietary herb and fiber combination (S&S PWH) in rats fed high-fat diet. J. Med. Food 2008, 11, 169–178. [CrossRef] [PubMed]
36. Koyama, Y.; Maebara, Y.; Hayashi, M.; Nagae, R.; Tokuyama, S.; Michinaga, S. Endothelins reciprocally regulate VEGF-A and angiopoietin-1 production in cultured rat astrocytes: Implications on astrocytic proliferation. Glia 2012, 60, 1954–1963. [CrossRef]
37. Shearer, K.D.; Fragoso, Y.D.; Clagett-Dame, M.; Mccaffery, P.; Tokuyama, S.; Michinaga, S. Astrocytes as a regulated source of retinoic acid for the brain. Glia 2012, 60, 1964–1976. [CrossRef]
38. Deedwania, P.C.; Pedersen, T.R.; Demicco, D.A.; Breazna, A.; Betteridge, D.J.; Hitman, G.A.; Durrington, P.; Neil, A. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes. Int. J. Cardiol. 2016, 222, 548–556. [CrossRef]
39. Wada, H.; Dohi, T.; Miyauchi, K.; Shitara, J.; Endo, H.; Doi, S.; Konishi, H.; Naito, R.; Tsuboi, S.; Ogita, M. et al. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease. Atherosclerosis 2017, 265, 35–40. [CrossRef] [PubMed]
40. Yamashita, H.; Fujisawa, K.; Ito, E.; Idei, S.; Kawaguchi, N.; Kimoto, M.; Hiemori, M.; Tsuji, H. Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Biosci. Biotechnol. Biochem. 2007, 71, 1236–1243. [CrossRef]
41. Reddy, J.K.; Rao, M.S. Lipid Metabolism and Liver Inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. 2006, 290, 852–858. [CrossRef] [PubMed]
42. Cho, A.S.; Jeon, S.M.; Kim, M.J.; Yeo, J.; Seo, K.I.; Choi, M.S.; Lee, M.K. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem. Toxicol. 2010, 48, 937–943. [CrossRef]
43. Bhutani, K.K.; Birari, R.B.; Kapat, K. Potential anti-obesity and lipid lowering natural products: A review. Nat. Prod. Commun. 2007, 2, 331–348.
44. Sunhee, C.; Miyeon, K.; Daieun, S. Spirulina prevents atherosclerosis by reducing hypercholesterolemia in rabbits fed a high-cholesterol diet. Sci. Vitaminol. 2010, 56, 34–40. [CrossRef]
45. Jin, D.; Xu, Y.; Mei, X.; Meng, Q.; Gao, Y.; Li, B. Antiobesity and lipid lowering effects of theaflavins on high-fat diet induced obese rats. J. Funct. Foods 2013, 5, 1142–1150. [CrossRef]
46. Torres-Duran, P.V.; Aldo, F.H.; Juarez-Oropeza, M.A. Antihyperlipemic and antihypertensive effects of Spirulina maximain an open sample of mexican population: A preliminary report. Lipids Health Dis. 2007, 6, 33. [CrossRef] [PubMed]
47. Singh, R.B.; Niaz, M.A.; Ghosh, S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc. Drugs Ther. 1994, 8, 659–664. [CrossRef]
48. Birari, R.; Javia, V.; Bhutani, K.K. Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats. Fitoterapia 2010, 81, 1129–1133. [CrossRef]
49. Chandrasekaran, C.V.; Vijayalakshmim, M.A.; Prakash, K. Review Article: Herbal Approach for Obesity Management. Am. J. Plant Sci. 2012, 3, 1003–1014. [CrossRef]
50. Kim, K.J.; Lee, M.S.; Jo, K.; Hwang, J.K. Piperidine alkaloids from Piper retrofractum Vahl. protect against high-fat diet-induced obesity by regulating lipid metabolism and activating AMP-activated protein kinase. Biochem. Biophys. Res. Commun. 2011, 411, 219–225. [CrossRef]
51. Sekiya, M.; Yahagi, N.; Matsuzaka, T.; Najima, Y.; Nakakuki, M.; Nagai, R.; Ishibashi, S.; Osuga, J.; Yamada, N.; Shimano, H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38, 1529–1539. [CrossRef] [PubMed]
52. Shimano, H.; Horton, J.D.; Shimomura, I.; EHammer, R.; Brown, M.S.; Goldstein, J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Investig. 1997, 99, 846–854. [CrossRef] [PubMed]
53. Yang, Z.X.; Shen, W.; Sun, H. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol. Int. 2010, 4, 741–748. [CrossRef] [PubMed]
54. Takahashi, N.; Senda, M.; Lin, S.; Goto, T.; Yano, M.; Sasaki, T.; Murakami, S.; Kawada, T. Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice. Mol. Nutr. Food Res. 2011, 55, 1791–1797. [CrossRef] [PubMed]
55. Nagasawa, T.; Inada, Y.; Nakano, S.; Tamura, T.; Takahashi, T.; Maruyama, K.; Yamazaki, Y.; Kuroda, J.; Shibata, N. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine-and choline-deficient diet. Eur. J. Pharmacol. 2006, 536, 182–191. [CrossRef] [PubMed]
56. EAkiyama, T.; Sakai, S.; Lambert, G. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 2002, 22, 2607–2619. [CrossRef]
57. Foretz, M.; Viollet, B. Regulation of hepatic metabolism by AMPK. J. Hepatol. 2011, 54, 827–829. [CrossRef] [PubMed]
58. Kim, J.B.; Spiegelman, B.M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996, 10, 1096–1107. [CrossRef] [PubMed]
59. Kim, J.B.; Wright, H.M.; Wright, M.; Spiegelman, B.M. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA 1998, 95, 4333–4337. [CrossRef]
60. Berger, J.P. Role of PPARgamma, transcriptional cofactors, and adiponectin in the regulation of nutrient metabolism, adipogenesis and insulin action: View from the chair. Int. J. Obes. 2005, 29, S3. [CrossRef]
61. Berger, J.; Moller, D.E. The mechanism of action of PPARs. Ann. Rev. Med. 2002, 53, 409–444. [CrossRef] [PubMed]
62. Lei, F.; Zhang, X.N.; Zhang, W.; Wang, D.; Xie, W.; Su, H.; Du, L.J. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int. J. Obes. 2007, 31, 1023. [CrossRef] [PubMed]
63. Herbert, T.; Moschen, A.R.; Kaneider, N.C. Pathways of liver injury in alcoholic liver disease. J. Hepatol. 2011, 55, 1159–1161. [CrossRef]
64. Dolan, K.T.; Chang, E.B. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol. Nutr. Food Res. 2016, 61, 1–38. [CrossRef]
65. Kimura, R.; Takahashi, N.; Murota, K.; Yamada, Y.; Niiya, S.; Kanzaki, N.; Murakami, Y.; Moriyama, T.; Goto, T.; Kawada, T. Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes. Biochem. Biophys. Res. Commun. 2011, 410, 1–6. [CrossRef] [PubMed]
66. Neyrinck, A.M.; Taminiau, B.; Walgrave, H.; Daube, G.; Cani, P.D.; Bindels, L.B.; Delzenne, N.M. Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota? Nutrients 2017, 9, 633–642. [CrossRef]
67. Fu, J.; Bonder, M.J.; Cenit, M.C.; Tigchelaar, E.F.; Maatman, A.; Dekens, J.A.M.; Brandsma, E.; Marczynska, J.; Imhann, F.; Weersma, R.K.; et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids. Circ. Res. 2015, 117, 817–824. [CrossRef]
68. Ubeda, C. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun. 2013, 81, 965–973. [CrossRef]
69. Shang, Q.; Song, G.; Zhang, M.; Zhang, M.F.; Shi, J.; Xu, C.; Hao, J.; Li, G.; Yu, G. Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia, population in the gut microbiota of high-fat diet-fed mice. J. Funct. Foods 2017, 28, 138–146. [CrossRef]
70. Brown, A.J.; Goldsworthy, S.M.; Barnes, A.A.; Eilert, M.M.; Tcheang, L.; Daniels, D.; Muir, A.I.; Wigglesworth, M.J.; Kinghorn, I.; Fraser, N.J.; et al. The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids. J. Biol. Chem. 2003, 278, 11312–11319. [CrossRef]
71. Henaomejia, J.; Elinav, E.; Jin, C.; Hao, L.; Mehal, W.Z.; Strowig, T.; Thaiss, C.A.; Kau, A.L.; Eisenbarth, S.C.; Jurczak, M.J.; et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482, 179–185. [CrossRef] [PubMed]
72. Ley, R.E.; Bäckhed, F.; Turnbaugh, P.; Lozupone, C.A.; Knight, R.D.; Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070–11075. [CrossRef] [PubMed]
73. Guo, W.L.; Pan, Y.Y.; Li, L.; Li, T.T.; Lv, X.C. Ethanol extract of Ganoderma lucidum ameliorates lipid metabolic disorders and modulates the gut microbiota composition in high-fat diet fed rats. Food Funct. 2018, 1–9. [CrossRef] [PubMed]
74. Zhao, L.N.; Wang, S.Y.; Huang, S.L.; Huang, Y.F. Optimization of Chelation of Whey Protein Hydrolysate with Calcium Using Response Surface Method. Adv. Mater. Res. 2013, 781–784, 1856–1860. [CrossRef]
75. Luo, Y.C.; Gang, C.; Bo, L.; Guo, Y.; Yetukuri, L.; VIslam, S.; Felin, J.; Perkins, R.; Borén, J.; Oresic, M.; et al. Evaluation of antioxidative and hypolipidemic properties of a novel functional diet formulation of Auricularia auricula and Hawthorn. Innov. Food Sci. Emerg. 2009, 10, 215–221. [CrossRef]
76. Friedewald, W.T.; Levy, R.I. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499–505. [PubMed]
77. Cheng, H.; Xu, N.; Zhao, W.; Su, J.; Lian, M.; Xie, Z.; Wu, X.; Li, Q. (−)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet†. Mol. Nutr. Food Res. 2017, 61, 1700303. [CrossRef]
78. Mashmoul, M.; Azlan, A.; Mohtarrudin, N. Protective effects of saffron extract and crocin supplementation on fatty liver tissue of high-fat diet-induced obese rats. BMC Complem. Altern. M. 2016, 16, 401–405. [CrossRef]
79. Hernándezrodas, M.C.; Valenzuela, R.; Echeverría, F.; Rincón-Cervera, M.Á.; Espinosa, A.; Illesca, P.; Muñoz, P.; Corbari, A.; Romero, N.; Gonzalez-Mañan, D.; et al. Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation. Mol. Nutr. Food Res. 2017, 61, 456–469. [CrossRef]
80. Li, K.; Zhuo, C.; Teng, C.; Yu, S.; Wang, X.; Hu, Y.; Ren, G.; Yu, M.; Qu, J. Effects of Ganoderma lucidum, polysaccharides on chronic pancreatitis and intestinal microbiota in mice. Int. J. Biol. Macromol. 2016, 93, 904–912. [CrossRef]
81. Henschel, A.; Anwar, M.Z.; Manohar, V. Comprehensive Meta-analysis of Ontology Annotated 16S rRNA Profiles Identifies Beta Diversity Clusters of Environmental Bacterial Communities. PLoS Comput. Biol. 2015, 11, e1004468. [CrossRef] [PubMed]